Document is current
Any future updates will be listed below
-
Authors
Pugin, Jérôme
Daix, Thomas
Pagani, Jean-Luc
Morri, Davide
Giacomucci, Angelo
Dequin, Pierre-François
Guitton, Christophe
Que, Yok-Ai
Zani, Gianluca
Brealey, David
Lepape, Alain
Creagh-Brown, Ben
Wyncoll, Duncan
Silengo, Daniela
Irincheeva, Irina
Girard, Laurie
Rebeaud, Fabien
Maerki, Iwan
Eggimann, Philippe
François, Bruno http://orcid.org/0000-0002-2531-1652
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03474809 at ClinicalTrials.govDocuments that mention this clinical trial
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study
https://doi.org/10.1186/s13054-021-03576-8
-
Funding
Funding for this research was provided by:
Abionic SA
- License Information
-
More Information
Article History
Received: 15 January 2021
Accepted: 13 April 2021
First Online: 20 April 2021
Declarations
:
: Approval was obtained from the ethics committees of all participating sites. The study has been registered at ClinicalTrials.gov (no. NCT03474809). Written informed consent to participation and any study-related assessment was obtained from all patients before their inclusion in the study. Written informed consent was obtained according to the specific requirements of each center’s ethics committee.
: N/A. The data presented are anonymized, so consent for publication is not required.
: Irina Irincheeva is affiliated with CTU Bern, University of Bern, which has a staff policy of not accepting honoraria or consultancy fees. However, CTU Bern is involved in design, conduct, or analysis of clinical studies funded by not-for-profit and for-profit organizations. In particular, pharmaceutical and medical device companies provide direct funding to some of these studies. For an up-to-date list of CTU Bern’s conflicts of interest seeExternalRef removed. Pierre-François Dequin declares that his institution (Centre Hospitalier Régional Universitaire de Tours, Tours, France) received grants for the inclusion of patients in the study. Bruno François declares receiving consultancy fees from Abionic. The other authors declare that they have no conflicts of interest.
